Almanac Between Issues

June 13, 2006


PENN’s Abramson Cancer Center and the Brain Tumor Society
Host One-Day Seminar for Patients, Survivors, and Caregivers

Brain Tumors: Confronting the Challenge Together


The Abramson Cancer Center and the national, non-profit Brain Tumor Society (BTS) are collaborating to offer a one-day seminar for pediatric and adult brain tumor patients, survivors, and caregivers. “Brain Tumors: Confronting the Challenge Together” will be held Saturday, June 17, in the ground floor auditorium of the Biomedical Research Building (BRB) II/III, Curie Boulevard and Osler Way, on the University of Pennsylvania’s School of Medicine campus.

The full-day seminar runs from 8 a.m. to 4 p.m., and will provide updates on the latest advances in standard and experimental therapies, guidance on integrating complementary and alternative medicine into treatment, coping strategies for families dealing with treatment and survivorship issues of children and adolescents, and an overview of emerging strategies on the horizon in brain tumor treatment.
In addition to the presentations and break-out sessions, there will also be an open forum where attendees will have the opportunity to ask the experts questions. “Thanks to the Internet and the media there is so much good information out there,” says Myrna R. Rosenfeld, MD, Ph.D, Chief of Neuro-Oncology at the University of Pennsylvania School of Medicine. “However, along with the good, also comes bad, unreliable information. There is just so much to sort through, it can be overwhelming. This type of event brings the patient, caregiver, and survivor populations together with the medical community in a forum where their questions and concerns can be addressed directly and correctly.”
“A seminar like this is so important for our patients and their loved ones,” said Sarah Gupta, LICSW, Director of Support Services at the Brain Tumor Society. “It’s absolutely essential for people affected by brain tumors to have opportunities to connect with others in similar situations. Patients, survivors, and caregivers may feel isolated in their experience until they meet other people facing the same challenges.”

Penn neuro-oncologists Myrna Rosenfeld, MD, PhD, and Amy Pruitt, MD, and neurosurgeons Kevin Judy, MD, and Donald O’Rourke, MD, are among the presenters from the Abramson Cancer Center’s Brain Tumor Program. Drs. Rosenfeld and O’Rourke are also a past recipients of the BTS research grant awards.

Other presenters represent a number of regional cancer centers, including Children’s Hospital of Philadelphia, Memorial Sloan-Kettering Cancer Center, Thomas Jefferson University Hospital, and Columbia University. Renowned physician Peter Phillips, MD, from Children’s Hospital, and member of the BTS Scientific Advisory Council, will also be presenting.

Each year, more than 200,000 adults and children in the United States are diagnosed with a primary or metastatic brain tumor. There are over 120 different types of brain tumors which are the leading cause of solid tumor cancer death in children up to age 19 and the second leading cause of cancer death in young adults ages 20 to 39. The brain – the organ of the body that controls the functions of all other organs – is responsible for the experience of the five senses and is the seat of thought, emotions, language, personality, creativity, and of course, memory. Because of their location in this extraordinarily complex and vital organ, brain tumors present unique challenges for patients, physicians, and caregivers alike.

For more information about “Brain Tumors: Confronting the Challenge Together” or to register, please visit www.tbts.org and click on “One-day Seminar Series” or call 1 800 770-8287. An all-inclusive fee of $25 per person includes breakfast, lunch, and parking.

 

 

 

Posted 6/13/06


Between Issues Archive | ALMANAC Home | Penn News Page